Leading the Future of Scientific Innovation
Event Recap : Revvity Signals NEXUS Europe 2025
August 5, 2025 Read Blog
Mary Donlan, Ph.D.
Executive Director, Product Marketing
Event Recap : Revvity Signals NEXUS Europe 2025
August 5, 2025 Read Blog
Executive Director, Product Marketing
Signals One unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze data so that scientists can focus on innovation.
Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals uses AI and other techniques to protect data.
Signals One™ has RNA specific tools for leading biopharmaceutical companies to make data-driven decisions. Learn how we meet chemists and RNA biologists needs.
Expediting Biosimilars to the Market with Electronic Laboratory Notebook, Signals Notebook.
Analytics-ready data is the foundation for successful AI implementation in clinical research.
India’s chemical industry is using AI and digital tools to boost sustainability and cut waste.
Smarter data analysis and automation tools help pharma firms accelerate time-to-market and boost R&D efficiency.
AI boosts brightfield imaging for fast, label-free cell analysis.
This article discusses how Indian CROs are driving a new era in pharmaceutical R&D, leveraging AI, data-driven insights, and digital platforms to accelerate drug discovery, boost efficiency, and enable global collaboration.
Expediting Biosimilars to the Market with Electronic Laboratory Notebook, Signals Notebook.
Effective R&D data management requires balancing structured and unstructured data types.
Analytics-ready data is the foundation for successful AI implementation in clinical research.
India’s chemical industry is using AI and digital tools to boost sustainability and cut waste.
Harness AI in drug discovery with unified, well-contextualized, and flexible data.
Smarter data analysis and automation tools help pharma firms accelerate time-to-market and boost R&D efficiency.
Discover how to accelerate innovation through data-driven formulation R&D workflows with Revvity Signals One.
How Signals One with AI Enhancement Empowers Researchers.
AI boosts brightfield imaging for fast, label-free cell analysis.
This article discusses how Indian CROs are driving a new era in pharmaceutical R&D, leveraging AI, data-driven insights, and digital platforms to accelerate drug discovery, boost efficiency, and enable global collaboration.
Discover six key best practices that help medical monitors detect risks early in clinical trials by leveraging data-driven insights and proactive monitoring strategies.
Discover how Revvity Signals' dedicated Customer Experience team helps clients build robust, efficient, and cost-effective research operations through expert support, innovative SaaS solutions, and a customer-first approach.